“Start low, go slow.” Geriatric pharmacology texts and recent systematic reviews (e.g., on dosing of oncology drugs) warn ...

Your money or your life” is a phrase attributed to robbers since time immemorial. The robber blurts it out, giving the victim ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

This is the first IL-23 receptor-targeted oral peptide pill, and it is also being evaluated as a treatment for psoriatic ...

Ruthless Kindness works with human service partners, such as women’s shelters, district attorneys offices, family justice center… NexGard (or afoxolaner) is a chewable prescription medication for dogs ...

The FDA has granted fast track designation to the anti-FcRn agent nipocalimab for the treatment of adults with systemic lupus erythematosus, according to a manufacturer press release. Nipocalimab ...

The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, Johnson & Johnson announced in a press release. Icotrokinra (Icotyde) is the ...

"The debate isn't about whether peptides work." The post Is It Safe to Inject Gray-Market Chinese Peptides? appeared first on Futurism.

Researchers at the George Washington University School of Medicine and Health Sciences in partnership with Baylor College of Medicine report encouraging results from a phase 2 clinical trial ...

FDA authorization covers moderate-to-severe plaque psoriasis in adults and patients aged ≥12 years, expanding systemic options for adolescents. Icotrokinra is characterized as a first-in-class ...

Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.

Uses, Dosage And Side Effects ...